Creative ePCR vs NY EMS Protocols Kullanım & İstatistikleri

Creative EMS Solutions is a technology organization focused on creating a more effective and profitable emergency medical community through the implementation of next generation software and high-yield billing. Creative EMS Solutions has been fortunate to service a multitude of EMS agencies and it is with the understanding that each is unique that we are proud to accommodate them all with uniquely customizable and professional services for both PC and tablet. Now we are releasing the industry’s first true IOS app. The Creative EMS ePCR is an unrivaled, NEMSIS Compliant solution. The "by-providers-for ­ providers", user-centric design separates the Creative software from our competitors who offer expensive systems built strictly from and behave like the NEMSIS Data Dictionary. Our first mission was to develop and refine an extremely user­ friendly and customizable user interface before bringing a product to market.
  • Apple App Store
  • BOŞTA
  • Medikal

Mağaza Sıralaması

- -

NY EMS Protocols is an easy to use app for EMS Providers in New York. It has protocols for the following jurisdictions: - New York City Basic Life Support - New York State Basic Life Support - New York City Advanced Life Support - Suffolk County Advanced Life Support - Nassau County Advanced Life Support Along with: - Medication Sheets - Local Resources & References This app aims to be a useful reference for the EMS Providers operating in NY.
  • Apple App Store
  • BOŞTA
  • Medikal

Mağaza Sıralaması

- -

Creative ePCR ile NY EMS Protocols için sıralama karşılaştırması

Son 28 gündeki Creative ePCR sıralama trendini NY EMS Protocolsile karşılaştırın

Rank

Mevcut veri yok

Creative ePCR vs. NY EMS Protocols ülke karşılaştırmasına göre sıralama

Son 28 gündeki Creative ePCR sıralama trendini NY EMS Protocolsile karşılaştırın

Gösterilecek bilgi yok

Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın

Başlayın
Creative ePCR VS.
NY EMS Protocols

Aralık 12, 2024